Targeted Therapy of Bronchiolitis Obliterans Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kirsten Williams
National Cancer Institute (NCI)
Study Chair - Stephanie Lee
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic - Scottsdale
Scottsdale, Arizona, United States
- Stanford University
Stanford, California, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- National Cancer Institute Experimental Transplantation & Immunology Branch
Bethesda, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States
- Siteman Cancer Center at Washington University
St Louis, Missouri, United States
- Weill Cornell Medical College
New York, New York, United States
- Vanderbilt University
Nashville, Tennessee, United States
- Fred Hutchinson Cancer Research Center/university of Washington Cancer Consortium
Seattle, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2011
- Primary completion
- 30 Sept 2014
- Completion
- 31 Dec 2015
- Last update posted
- 4 Oct 2017
- Registered enrollment
- 36
- Registry id
- NCT01307462
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.